Login / Signup

Small-Molecule Activators of Glucose-6-phosphate Dehydrogenase (G6PD) Bridging the Dimer Interface.

Andrew G RaubSunhee HwangNaoki HorikoshiAnna D CunninghamSimin RahighiSoichi WakatsukiDaria-Mochly Rosen
Published in: ChemMedChem (2019)
We recently identified AG1, a small-molecule activator that functions by promoting oligomerization of glucose-6-phosphate dehydrogenase (G6PD) to the catalytically competent forms. Biochemical experiments indicate that the activation of G6PD by the original hit molecule (AG1) is noncovalent and that one C2 -symmetric region of the G6PD homodimer is important for ligand function. Consequently, the disulfide in AG1 is not required for activation of G6PD, and a number of analogues were prepared without this reactive moiety. Our study supports a mechanism of action whereby AG1 bridges the dimer interface at the structural nicotinamide adenine dinucleotide phosphate (NADP+ ) binding sites of two interacting G6PD monomers. Small molecules that promote G6PD oligomerization have the potential to provide a first-in-class treatment for G6PD deficiency. This general strategy could be applied to other enzyme deficiencies in which control of oligomerization can enhance enzymatic activity and/or stability.
Keyphrases
  • small molecule
  • blood pressure
  • risk assessment
  • nitric oxide
  • adipose tissue
  • immune response
  • hydrogen peroxide
  • toll like receptor
  • human health
  • combination therapy